Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ADMA Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
ADMA Biologics Acquires Certain Assets from Biotest Pharma 11
Venture Financing 13
ADMA Biologics Secures USD20 Million from Oxford Finance 13
Adma Biologics Secures USD5 Million from Hercules 14
ADMA Biologics Secures Venture Funding from Biomark Capital 16
ADMA Plasma Biologics Raises US$17.6 Million In Venture Financing 17
Licensing Agreements 18
Adma Biologics Enters Into Licensing Agreement With Biotest Pharma For RSV Immune Globulin 18
Adma Biologics Amends Licensing Agreement With Biotest For IGIV 19
Adma Biologics Enters Into Licensing Agreement With Biotest For Varicella Zoster Immune Globulin 20
Equity Offering 21
ADMA Biologics Raises USD40 Million in Public Offering of Shares 21
ADMA Biologics to Raise Funds through Public Offering of Shares 23
ADMA Biologics Raises USD42 Million in Public Offering of Shares 24
ADMA Biologics Plans to Raise Funds through Secondary Offering of Shares 26
ADMA Biologics Raises USD14 Million in Public Offering of Shares 28
ADMA Biologics Raises USD11.2 Million in Public Offering of Shares 30
ADMA Biologics Completes IPO For US$28.5 Million 32
ADMA Biologics Raises USD17.6 Million in Private Placement of Shares 33
Acquisition 35
R&R Acquisition Acquires ADMA Biologics In Reverse Acquisition 35
ADMA Biologics Inc – Key Competitors 36
ADMA Biologics Inc – Key Employees 37
ADMA Biologics Inc – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Financial Announcements 39
Aug 10, 2018: ADMA Biologics reports second quarter 2018 financial results 39
May 14, 2018: ADMA Biologics Reports First Quarter 2018 Financial Results 41
Mar 05, 2018: ADMA Biologics Announces Full Year 2017 Financial Results 42
Nov 03, 2017: ADMA Biologics Provides Corporate Update and Reports Third Quarter 2017 Financial Results 43
Aug 11, 2017: ADMA Biologics Provides Corporate Update and Reports Second Quarter 2017 Financial Results 45
May 12, 2017: ADMA Biologics Provides Corporate Update and Reports First Quarter 2017 Financial Results 47
Feb 24, 2017: ADMA Biologics Reports Year End 2016 Financial Results, Accomplishments and Upcoming Milestones 48
Legal and Regulatory 49
Jul 26, 2018: Adma Biologics reports successful close-out of its April 2018 FDA compliance inspection 49
Other Significant Developments 50
Jun 27, 2017: ADMA Biologics Provides Corporate Timeline and Activities Update to Stockholders 50
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ADMA Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ADMA Biologics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ADMA Biologics Acquires Certain Assets from Biotest Pharma 11
ADMA Biologics Secures USD20 Million from Oxford Finance 13
Adma Biologics Secures USD5 Million from Hercules 14
ADMA Biologics Secures Venture Funding from Biomark Capital 16
ADMA Plasma Biologics Raises US$17.6 Million In Venture Financing 17
Adma Biologics Enters Into Licensing Agreement With Biotest Pharma For RSV Immune Globulin 18
Adma Biologics Amends Licensing Agreement With Biotest For IGIV 19
Adma Biologics Enters Into Licensing Agreement With Biotest For Varicella Zoster Immune Globulin 20
ADMA Biologics Raises USD40 Million in Public Offering of Shares 21
ADMA Biologics to Raise Funds through Public Offering of Shares 23
ADMA Biologics Raises USD42 Million in Public Offering of Shares 24
ADMA Biologics Plans to Raise Funds through Secondary Offering of Shares 26
ADMA Biologics Raises USD14 Million in Public Offering of Shares 28
ADMA Biologics Raises USD11.2 Million in Public Offering of Shares 30
ADMA Biologics Completes IPO For US$28.5 Million 32
ADMA Biologics Raises USD17.6 Million in Private Placement of Shares 33
R&R Acquisition Acquires ADMA Biologics In Reverse Acquisition 35
ADMA Biologics Inc, Key Competitors 36
ADMA Biologics Inc, Key Employees 37
ADMA Biologics Inc, Subsidiaries 38
List of Figures
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9